IP Library Patent Application 18470256
Patent Application
App. No. 18/470,256

EPINEPHRINE FORMULATIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/470,256
Abstract

Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.

Claims (17)

1 . A composition comprising:

in the range of about 0.1 to 2 mg/mL of epinephrine and/or salts thereof,

in the range of about 6 to 8 mg/mL of a tonicity regulating agent,

in the range of about 2.8 to 3.8 mg/mL of a pH raising agent,

in the range of about 0.1 to 1.1 mg/mL of an antioxidant,

in the range of about 0.001 to 0.010 mL/mL of a pH lowering agent,

in the range of about 0.01 to 0.4 mg/mL of a transition metal complexing agent,

wherein the antioxidant comprises sodium bisulfite and/or sodium metabisulfite.

2 . The composition of claim 1 , wherein the composition has an initial pH in a range of about 3.5 to 4.5.

3 . The composition of claim 2 , wherein a pH range of the composition after 18 months of storage at between 23° C. and 32° C. and between 55% RH and 70% RH is no more than about 1 unit different from the initial pH of the composition.

4 . The composition of claim 1 , wherein the pH raising agent comprises a buffer system comprising at least two compounds.

5 . The composition of claim 4 , wherein the pH raising agent comprises at least one of tartaric acid and sodium hydroxide.

6 . The composition of claim 1 , wherein the pH lowering agent comprises hydrochloric acid.

7 . The composition of claim 1 , further comprising a preservative.

8 . The composition of claim 7 , wherein the preservative comprises chlorobutanol.

9 . The composition of claim 1 , further comprising a solvent.

10 . The composition of claim 9 , wherein the solvent comprises water.

Assignments (5)
SECURITY INTEREST Recorded Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
SECURITY INTEREST Recorded Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0492 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2024
From: PAR PHARMACEUTICAL, INC.
To: ENDO USA, INC.
Reel/Frame 067203/0686 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2023
From: SANGHVI, SUKETU; KANNAN, VINAYAGAM; KENNEY, MATTHEW
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 064964/0467 →